Concord Biotech’s niche API play holds promise for growth

August 4, 2023

ET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than 70 countries, including regulated markets like the United States, Europe and Japan.

More To Explore

Market dips are a buy opportunity, not a concern: Varun Saboo

Varun Saboo from Anand Rathi Shares suggests viewing market corrections as buying opportunities. He highlights India’s strong economic fundamentals, including infrastructure spending and RBI’s rate

June 18, 2025

Delhivery shares surge 2% as CCI approves Rs 1,407-crore Ecom Express deal

The Competition Commission of India has approved Delhivery’s acquisition of Ecom Express. This deal is worth approximately Rs 1,407 crore. It will significantly consolidate India’s

June 18, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003